In the present study, the expression of p-mTOR, together with its activators (i.e., p-Akt, p-AMPK) and downstream effectors (i.e., p-p70S6K and p-RPS6) was more intense in the tumour edge. Here, RPS6KB1 is linked to neoplasm.